- ►diabetesjournals.org RJ Brown, N Sinaii, KI Rother - Diabetes Care, 2008 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—Glucagon and C-peptide concentrations were determined
in response to standard mixed meals in 23 patients with type 1 diabetes aged 9.4 ± 4.6
years, beginning within 6 weeks of diagnosis, and every 3 months thereafter for 1 year. Cited by 2 - Related articles - All 6 versions
JM Sosenko, JP Palmer, L Rafkin-Mervis, JP … - Diabetes Care, 2008 - Am Diabetes Assoc RESULTS—Glucose levels increased at 90 (P = 0.006) and 120 min (P < 0.001) from the initial
diabetic OGTT to the confirmatory diabetic OGTT (mean ± SD interval 5.5 ± 2.8 weeks). Peak
C-peptide levels fell substantially between the OGTTs (median change −14.3%, P < ... Cited by 5 - Related articles - All 3 versions
- ►diabetesjournals.org A Petrone, M Spoletini, S Zampetti, M Capizzi, S … - Diabetes Care, 2008 - Am Diabetes Assoc OBJECTIVE—Evidence has been reported for a new susceptible locus for type 1 diabetes, the
protein tyrosine phosphatase nonreceptor type 2 (PTPN22), which encodes a lymphoid-specific
phosphatase. The aim of the study was to evaluate the influence of the C1858T variant of ... Cited by 3 - Related articles - BL Direct - All 5 versions
P Luppi, V Cifarelli, H Tse, J Piganelli, M Trucco - Diabetologia, 2008 - Springer Abstract Aims/hypothesis Endothelial dysfunction in diabetes is pre- dominantly caused by hyperglycaemia
leading to vascular complications through overproduction of oxidative stress and activation of
the transcription factor nuclear factor-κB (NF-κB). Many studies have suggested that ... Cited by 5 - Related articles - All 2 versions
[CITATION] Effects of age, duration and treatment of insulin dependent diabetes mellitus on …
MA Sperling, K Aleck, S Voina - The Journal of Pediatrics, 1977 - Elsevier The suppressibility of plasma glucagon concentrations by glucose was investigated in normal
and diabetic children. Fasting concentrations of plasma glucagon were similar in normal and
in diabetic children despite the hyperglycemia of the latter. Infusion of glucose promptly ... Cited by 6 - Related articles - All 4 versions
EP Activity - Ann Intern Med, 1998 - Am Coll Physicians Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the
diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control
and Complications Trial Research Group Ann Intern Med 128, 517-523, 1998.
Cited by 8
HP Chase, K Lutz, R Pencek, B Zhang, L Porter - The Journal of Pediatrics, 2009 - Elsevier In 9 evaluable subjects, plasma pramlintide concentrations increased dose-proportionately; mean
peak plasma concentration (C max ) (15-μg dose, 93 ± 9 pg/mL; 30-μg dose, 202 ± 21
pg/mL) occurred 0.3 h (median time to peak concentration) after administration. ... Cited by 2 - Related articles - All 18 versions
JP Palmer - Diabetes Metab Res Rev, 2009 - interscience.wiley.com Type 1 diabetes is diagnosed when the patient's endogenous insulin secretion decreases to
a level which results in hyperglycemia. After diagnosis, insulin secretion continues to
decline. As a reference for clinical trials trying to preserve endogenous beta-cell function ... Cited by 2 - Related articles - All 2 versions
